Dorit Donoviel

Dorit Donoviel, Ph.D., serves as Executive Director for the Translational Research Institute for Space Health (TRISH), a NASA-funded virtual institute led by Baylor College of Medicine (BCM) in Houston, TX with the California Institute of Technology and Massachusetts Institute of Technology. Under Dr. Donoviel’s leadership, the mission of the TRISH is to lead a national effort in translating cutting edge emerging terrestrial biomedical research and technology development into applied space flight human risk mitigation strategies for human exploration missions. Prior to TRISH, Dr. Donoviel served as deputy chief scientist and Industry Lead for the National Space Biomedical Research Institute (NSBRI). Before her work with TRISH and NSBRI, Dr. Donoviel worked in the private sector, where she led metabolism drug discovery programs at Lexicon Pharmaceuticals in Houston, TX. Dr. Donoviel is the recipient of awards from the NASA Human Research Program and was awarded the NSBRI Pioneer Award. She continues to author numerous scientific articles and papers in academic journals and is a sought-after expert for interviews by news organizations, both regionally, nationally, and internationally. Dr. Donoviel is an Associate Professor in the Dept. of Pharmacology & Chemical Biology and the Center for Space Medicine at Baylor College of Medicine.